Scancell Holdings (SCLP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 9.85p
   
  • Change Today:
      0.000p
  • 52 Week High: 16.50
  • 52 Week Low: 7.50
  • Currency: UK Pounds
  • Shares Issued: 1,037.78m
  • Volume: 0
  • Market Cap: £102.22m
  • Beta: 0.84

Latest Trades

Time Price Volume Value Buy/Sell Type
05-Nov-2025 16:29 10.08p 6,000 £605 Buy O
05-Nov-2025 16:28 10.08p 6,000 £605 Buy O
05-Nov-2025 16:27 10.08p 50,000 £5,040 Buy O
05-Nov-2025 16:23 10.05p 52,937 £5,320 Buy O
05-Nov-2025 14:28 9.99p 100,000 £9,990 Buy O
05-Nov-2025 14:23 9.99p 10,000 £999 Buy O
05-Nov-2025 14:16 9.99p 50,000 £4,995 Buy O
05-Nov-2025 14:09 9.99p 1,111 £111 Buy O
05-Nov-2025 13:34 10.18p 982 £100 Buy O
05-Nov-2025 12:16 9.99p 20,000 £1,998 Buy O
05-Nov-2025 11:45 9.99p 365 £36 Buy O
05-Nov-2025 08:30 10.00p 3,910 £391 Buy O
05-Nov-2025 08:06 9.99p 2,002 £200 Buy O
05-Nov-2025 08:01 9.83p 4,083 £401 Sell O

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SCLP Market Data

Currency UK Pounds
Share Price 9.85p
Change Today 0.000p
% Change 0.00 %
52 Week High 16.50
52 Week Low 7.50
Volume 0
Shares Issued 1,037.78m
Market Cap £102.22m
Beta 0.84

SCLP Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average19.67% below the market average
18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average18.18% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 3
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SCLP Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

SCLP Key Personnel

CFO Sath Nirmalananthan
CEO Phil L'Huillier

Top of Page